JPMorgan Chase & Co. Issues Pessimistic Forecast for H.B. Fuller (NYSE:FUL) Stock Price

H.B. Fuller (NYSE:FUL) had its target price lowered by investment analysts at JPMorgan Chase & Co. from $60.00 to $50.00 in a research report issued on Friday,Benzinga reports. The firm currently has an “underweight” rating on the specialty chemicals company’s stock. JPMorgan Chase & Co.‘s price target would indicate a potential downside of 8.69% from the company’s current price.

Several other equities analysts have also recently commented on the company. Citigroup reduced their target price on H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. Vertical Research lowered H.B. Fuller from a “buy” rating to a “hold” rating in a report on Monday, January 6th. Seaport Res Ptn downgraded shares of H.B. Fuller from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 5th. Finally, Deutsche Bank Aktiengesellschaft cut their price target on shares of H.B. Fuller from $75.00 to $72.00 and set a “buy” rating for the company in a research note on Wednesday, January 22nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, H.B. Fuller currently has an average rating of “Hold” and a consensus price target of $70.00.

H.B. Fuller Stock Down 5.0 %

FUL stock opened at $54.76 on Friday. The stock has a 50-day simple moving average of $58.31 and a two-hundred day simple moving average of $68.68. H.B. Fuller has a twelve month low of $52.59 and a twelve month high of $87.67. The firm has a market capitalization of $2.97 billion, a PE ratio of 23.70, a PEG ratio of 1.13 and a beta of 1.41. The company has a quick ratio of 1.16, a current ratio of 1.81 and a debt-to-equity ratio of 1.10.

H.B. Fuller (NYSE:FUL) last posted its earnings results on Wednesday, March 26th. The specialty chemicals company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.05. H.B. Fuller had a net margin of 3.65% and a return on equity of 12.01%. The business had revenue of $788.66 million for the quarter, compared to analyst estimates of $769.55 million. During the same quarter in the prior year, the firm posted $0.67 EPS. H.B. Fuller’s revenue was down 2.7% on a year-over-year basis. On average, equities analysts predict that H.B. Fuller will post 4.07 EPS for the current fiscal year.

Institutional Investors Weigh In On H.B. Fuller

A number of large investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC boosted its stake in shares of H.B. Fuller by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock worth $99,939,000 after buying an additional 18,734 shares during the last quarter. Lord Abbett & CO. LLC lifted its holdings in H.B. Fuller by 79.8% in the third quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock valued at $57,952,000 after acquiring an additional 324,056 shares during the period. Wesbanco Bank Inc. boosted its position in H.B. Fuller by 41.2% in the fourth quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock worth $924,000 after purchasing an additional 4,000 shares during the last quarter. Bank of New York Mellon Corp grew its stake in shares of H.B. Fuller by 17.2% during the 4th quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company’s stock valued at $37,448,000 after purchasing an additional 81,558 shares during the period. Finally, Jones Financial Companies Lllp increased its position in shares of H.B. Fuller by 128.8% during the 4th quarter. Jones Financial Companies Lllp now owns 899 shares of the specialty chemicals company’s stock valued at $61,000 after purchasing an additional 506 shares during the last quarter. Institutional investors own 95.93% of the company’s stock.

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.